Updates are available Correction dated 2022-05-10
Click to view Correction: https://doi.org/10.1007/s12311-022-01413-4
-
Authors
Cabaraux, Pierre https://orcid.org/0000-0001-9054-3081
Agrawal, Sunil K.
Cai, Huaying
Calabro, Rocco Salvatore
Casali, Carlo
Damm, Loic
Doss, Sarah
Habas, Christophe
Horn, Anja K. E.
Ilg, Winfried
Louis, Elan D.
Mitoma, Hiroshi
Monaco, Vito
Petracca, Maria
Ranavolo, Alberto
Rao, Ashwini K.
Ruggieri, Serena
Schirinzi, Tommaso
Serrao, Mariano
Summa, Susanna
Strupp, Michael
Surgent, Olivia
Synofzik, Matthis
Tao, Shuai
Terasi, Hiroo
Torres-Russotto, Diego
Travers, Brittany
Roper, Jaimie A.
Manto, Mario
- License Information
-
More Information
Article History
Accepted: 20 January 2022
First Online: 12 April 2022
Change Date: 10 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12311-022-01413-4
Declarations
:
: Not applicable.
: All co-authors provided consent to publication of the findings in medical journal.
: M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, J&J, MSD, Otometrics, Pierre-Fabre, TEVA, UCB, and Viatris. He is a share holder and investor of IntraBio. He distributes “M-glasses” and “Positional vertigo App”. He acts as a consultant for Abbott, AurisMedical, Heel, IntraBio and Sensorion.The other authors declare no conflict of interest.
